Allocation of Resources Between Smoking Cessation Methods and Lovastatin Treatment of Hypercholesterolaemia: Based on Cost Effectiveness and the Social Welfare Function

Author： Plans-Rubió P.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.1, 2004-01, pp. : 55-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Encouraging Smokers to Quit: The Cost Effectiveness of Reimbursing the Costs of Smoking Cessation Treatment

By Kaper Janneke  

PharmacoEconomics, Vol. 24, Iss. 5, 2006-01 ,pp. : 453-464

Adis International

Access to resources Recommend Favorite

A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease

By Lock Kevin   Wilson Koo   Murphy Daniel   Riesco Juan Antonio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2613-2626

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation: A BENESCO Markov Cost-Effectiveness Analysis

By Annemans Lieven  

Clinical Drug Investigation, Vol. 29, Iss. 10, 2009-10 ,pp. : 655-665

Adis International

Access to resources Recommend Favorite

Varenicline: progress in smoking cessation treatment

By Glover Elbert D   Rath Jessica M  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1757-1767

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of Bupropion for Smoking Cessation During Pregnancy

By Chan Brian   Einarson Adrienne   Koren Gideon  

Journal of Addictive Diseases, Vol. 24, Iss. 2, 2005-03 ,pp. : 19-23

Haworth Press

Access to resources Recommend Favorite